The cumulative long-term survival of mice from all groups from three experiments followed out to 150 days post tumor inoculation showed that IL-21 + IL-2 treated mice had significantly better survival (46%) compared to all other groups (Figure 2F). This evidence concerns the gene IL2 and neoplasm.